| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.0073 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |